The Test Your Memory (TYM) screen, when combined with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and supplemented with executive and language tests such as the Colour Trail Test (CTT) and modified Boston Naming Test (mBNT), effectively detects cognitive impairment (CI), according to a recent Singapore study.
Amyloid beta (Aβ) burden was associated with decline in white matter microstructure — one of the pathological hallmarks of Alzheimer’s disease (AD) — in cognitively normal elderly people, according to data from the Singapore’s Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Children who are physically active from an early age may have a reduced risk of developing adolescent onset idiopathic scoliosis (AIS), based on findings of the prospective, UK population-based ALSPAC* study.
The long-term risk of cardiovascular (CV) events in patients with acute coronary syndrome (ACS) is elevated when they have concomitant polyvascular disease* and type 2 diabetes (T2D), according to a post-hoc analysis of the IMPROVE-IT** trial.
Calcitonin gene-related peptide (CGRP)-directed therapy with erenumab appears to effectively reduce the number of migraine days in patients with episodic migraine who have failed other preventive treatments due to lack of efficacy or low tolerability, according to the results of the phase IIIb LIBERTY trial.